
Analyst Insights
Denali Therapeutics Inc (DNLI) poses a Brand-New Opportunity for Investors with beta value of 1.33
As on Thursday, Denali Therapeutics Inc (NASDAQ: DNLI) started slowly as it slid -1.39% to $14.22, before settling in for the price of $14.42 at